NFKB1 and atherosclerosis: MiR-146, a negative regulator of atherosclerosis and inflammation, mediated the CXCL16 expression induced by LPS in a TLR4-dependent manner and controlled the inflammation induced by NF-κB through a negative feedback loop [145].